Enhanced American College of Cardiology/American Heart Association Strategy for Prevention of Sudden Cardiac Death in High-Risk Patients With Hypertrophic CardiomyopathyMartin S. Maron, Barry J. Maron|JAMA Cardiology|2019Cited by 311
Aficamten for Symptomatic Obstructive Hypertrophic CardiomyopathyMartin S. Maron, Theodore P. Abraham, Pablo García‐Pavía et al.|New England Journal of Medicine|2024Cited by 277
Phase 2 Study of Aficamten in Patients With Obstructive Hypertrophic CardiomyopathyMartin S. Maron, Theodore P. Abraham, Ahmad Masri et al.|Journal of the American College of Cardiology|2023Cited by 192
Research Priorities in Hypertrophic CardiomyopathyThomas Force, Christine E. Seidman, Robert O. Bonow et al.|Circulation|2010Cited by 118
2020 AHA/ACC guideline for the diagnosis and treatment of patients with hypertrophic cardiomyopathySteve R. Ommen, Y. Joseph Woo, Seema Mital et al.|Journal of Thoracic and Cardiovascular Surgery|2021Cited by 89